The article discusses the debate around drug pricing in the UK. The author argues that the UK's system for evaluating the cost-effectiveness of new drugs is respected globally and has led to widespread price reductions, allowing the National Health Service (NHS) to benefit. The article refutes the claim by the chief executive of Eli Lilly that the UK is the "worst country in Europe" for drug prices, stating that the recent pausing or cancelling of pharmaceutical industry investments in the UK is due to the companies' desperation to appease former US President Donald Trump, not the UK's drug pricing policies. The author suggests that the NHS should celebrate its drug pricing system, which upholds the principle that funding a new product should not damage the NHS as a whole.
Oct 15, 2025 → Oct 16, 2025
The article reports that shares of pharmaceutical companies Eli Lilly and Novo Nordisk fell in late trading after President Donald Trump stated that the price of the diabetes drug Ozempic could be lowered to around $150 per month. Ozempic…
Read original at Bloomberg →2 updates from 2 sources over 1 day.
The article reports that shares of pharmaceutical companies Eli Lilly and Novo Nordisk fell in late trading after President Donald Trump stated that the price of the diabetes drug Ozempic could be lowered to around $150…
Read original at Bloomberg →The article discusses the debate around drug pricing in the UK. The author argues that the UK's system for evaluating the cost-effectiveness of new drugs is respected globally and has led to widespread price reductions,…
Read original at The Guardian →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
The article reports that shares of pharmaceutical companies Eli Lilly and Novo Nordisk fell in late trading after President Donald Trump stated that the price of the diabetes drug Ozempic could be lowered to around $150 per month. Ozempic…
View source →The article discusses the debate around drug pricing in the UK. The author argues that the UK's system for evaluating the cost-effectiveness of new drugs is respected globally and has led to widespread price reductions, allowing the…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
